Mkt Cap (₹ Cr.)
Face Value (₹)
- Disclosures under Reg. 31(1) and 31(2) of SEBI (SAST) Regulations, 2011.
- Announcement under Regulation 30 (LODR)-Newspaper Publication
- Fixes Record Date for Interim Dividend
Sun Pharmaceutical Industries Ltd. Share Price Updates
Earnings(Figures in Rs. Cr.)
Financial Comparison with peers
Mutual Fund Ownership
(in ₹ Cr)
Sun Pharmaceutical Industries Ltd., incorporated in the year 1993, is a Large Cap company (having a market cap of Rs 98048.82 Crore) operating in Pharmaceuticals sector.
Sun Pharmaceutical Industries Ltd. key Products/Revenue Segments include Pharmaceuticals which contributed Rs 9783.29 Crore to Sales Value (94.95 % of Total Sales) and Other Operating Revenue which contributed Rs 519.92 Crore to Sales Value (5.04 % of Total Sales)for the year ending 31-Mar-2019.
For the quarter ended 31-12-2019, the company has reported a Consolidated sales of Rs 8038.65 Crore, up 1.13 % from last quarter Sales of Rs 7949.19 Crore and up 4.99 % from last year same quarter Sales of Rs 7656.71 Crore Company has reported net profit after tax of Rs 1023.71 Crore in latest quarter.
The company’s top management includes Mr.Ashwin Dani, Mr.Sudhir V Valia, Mr.Sailesh T Desai, Mr.S Mohanchand Dadha, Mr.Keki M Mistry, Mr.Kalyanasundaram Subramanian, Mr.Israel Makov, Mr.Hasmukh S Shah, Mr.Dilip S Shanghvi, Ms.Rekha Sethi. Company has S R B C & Co. LLP as its auditors As on 31-12-2019, the company has a total of 2,399,334,970 shares outstanding.